Treatment with tumour necrosis factor α antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies

Схожие документы

• Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense
  по: van Vollenhoven, R, et al.
  Опубликовано: (2003)
• Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis
  по: Padyukov, L, et al.
  Опубликовано: (2003)
• Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
  по: Askling, J, et al.
  Опубликовано: (2005)
• Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
  по: Askling, J, et al.
  Опубликовано: (2005)
• Effect of tumour necrosis factor α antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection
  по: Peterson, J, et al.
  Опубликовано: (2003)